Intra-uterine pressure was recorded by placing a Foley catheter in the extra-amniotic space before the termination of pregnancy in 25 patients, and Caesarean section in 12 patients. The effects of administration of i.v. ketamine 2 mg/kg body weight, sodium thiopentone 4 mg/kg body weight and ergometrine 0.5 mg, and intra-cervical 0.5% lignocaine 20 ml were measured in the first trimester of pregnancy, and i.v. ketamine and sodium thiopentone in late pregnancy. Ketamine was found to cause uterine contraction (mean increase 16.1 mm Hg) equal to ergometrine (mean increase 14.8 mm Hg) in early pregnancy, but exert no effect (mean decrease -1.33 mm Hg) in late pregnancy. Lignocaine in early pregnancy given as a paracervical block had no significant effect on intrauterine pressure (mean increase 0.33 mm Hg). Sodium thiopentone (mean decrease -4.28 mm Hg first trimester and -2.22 mm Hg at term) in late pregnancy had no significant effect on intra-uterine pressure.
Ketamine hydrochloride (Ketalar) has been used widely in anaesthetic practice since the initial paper by Domino, Chodoff and Corssen (1965) . In 1971 Galloon reported on its use as an induction agent for the termination of pregnancy by suction curettage, noting that blood loss was minimal during the procedure and that the uterus was well contracted at the conclusion of the operation. Later, Galloon (1973) measured the effect of ketamine on uterine muscle at hysterotomy and found an increase in both uterine tone and the intensity of contractility. Such effects had not been observed by Peltz and Sinclair (1973) on a pregnant uterus at term at Caesarean section, and thus it was decided to investigate further the action of ketamine and compare it with that of thiopentone in the first and last trimester of pregnancy and with ergometrine and lignocaine in early pregnancy.
PATIENTS AND METHODS
The procedure was explained to and informed consent obtained from 19 women undergoing therapeutic termination of pregnancy under general anaesthesia who were allocated randomly to three groups. The first group (I) received ketamine, the second (II) thiopentone and the third (III) ergometrine followed by ketamine. An oral premedication of lorazepam 3 mg and droperidol 5 mg was given 1 h before the induction of anaesthesia. A further six women (group IV) chose to have termination of pregnancy under local anaesthesia; no premedication was given to these patients.
In a second study, 12 women prepared for elective Caesarean section on account of cephalopelvic disproportion were allocated randomly to two groups. The first (group V) were given ketamine and the other (group VI) thiopentone for the induction of anaesthesia. In keeping with our routine practice for elective Caesarean section, the patients were not premedicated, and breathed 100% oxygen until the trachea was intubated. As soon as the intrauterine pressure had been measured (vide infra) the patients were given suxamethonium i.v., an endotracheal tube was inserted and the lungs were ventilated in the normal manner. The anaesthetic was continued using conventional techniques and the intra-uterine catheter removed.
Before the induction of anaesthesia each patient was placed in the lithotomy position, the vulva and vagina were cleaned with chlorhexidine solution 0.5% and, after draping with sterile towels, a bivalve speculum was inserted into the vagina to display the cervix. A size 12 Foley catheter was fed through the cervix into the extra-amniotic space and the selfretaining balloon distended with 5 ml of saline. The catheter filled with saline was connected to a Bell and Howell transducer and the pressure recorded on a Devices recorder after calibration. Once a steady baseline pressure had been obtained for 3 min, ketamine 2 mg kg" 1 body weight i.v. was given to groups I and V, thiopentone 4 mg kg" 1 body weight i.v. to groups II and VI , and ergometrine 0.5 mg i.v. to group III. In group IV, lignocaine 0.5% 20 ml was injected in four divided doses at "12, 3, 6, and 9 o'clock" at the junction of the inner § and the outer \ of the cervix. The intra-uterine pressure was recorded continuously until a steady state had been reached for a further 3 min. In group III ketamine 2 ml kg" 1 body weight i.v. was administered and the recording of intrauterine pressure continued until a new steady state had been obtained. The catheter was removed and the planned operation performed. No anaesthetic or surgical complications occurred. These was no case of post-abortion or puerperal infection.
The period of gestation at termination of pregnancy ranged from 8 to 12 week and at Caesarean section from 37 to 40 week. The F test was used to test for equality of variance before comparison of means. If the F test was positive, Student's t test was used; if not, a modified Student's / was applied.
RESULTS
The changes in intra-uterine pressure in the six groups are shown in figure 1 and the mean changes and SEM are listed in table I. The significance of the comparison of these means is detailed in table II. From these data it can be seen that the action of ketamine was quite different in early and in late pregnancy. In the first trimester it produced an increase in intra-uterine pressure comparable to that produced by ergometrine, whilst at term a decrease in intra-uterine tone was recorded, although this was not statistically significant. Thiopentone and lignocaine induced little change in intra-uterine pressure; the decrease noted in group II, although consistent, was not statistically significant.
Blood loss was measured at termination of pregnancy. The means for each group were 125, 150, 182 and 75 ml respectively. Because of inaccuracies inherent in estimations not employing a "washing machine" technique and the difficulties in allowing for fetal and liquor volume, these differences were not subjected to statistical analysis.
No patient reported unpleasant dreams or exhibited disturbed behaviour patterns in the recovery period. This is in keeping with our experience when using lorazepam plus droperidol as a premedicant. Simpson and colleagues (1974) reported no increase in peripheral oxytocin concentrations during the administration of ketamine, which suggests that its action is not mediated by oxytocin. Furthermore, they found that pharmacological concentrations of ketamine were not associated with contraction of the isolated pregnant uterine muscle strips, although these did respond to noradrenaline. In this study we found that, after a pressure plateau had been attained following the administration of ergometrine, there was a further, and equal, increase in intrauterine pressure with the subsequent injection of ketamine. Therefore, uterine muscle was not stimulated maximally by ergometrine 0.5 mg and was capable of further contraction. The response of the human myometrium to oxytocin changes markedly during pregnancy. It is resistant to its action except in very great concentrations until the onset of labour when there is a rapid increase in sensitivity (Theobald, Robards and Suter, 1969) . The reaction of uterine muscle to ketamine is quite different, suggesting that this action is not mediated by oxytocin.
DISCUSSION
Unlike ketamine, prostaglandins E 2 and F 2 a have a relatively uniform effect on uterine muscle throughout pregnancy. This would indicate that ketamine does not act directly through the release of prostaglandin or, if it does, its action is modified considerably by other hormonal changes.
Ketamine has been shown by Unni and Bovill (1972) to release both noradrenaline and adrenaline. Human myometrium contains a-and (3-adrenergic receptors, the former being stimulatory and the latter inhibitory to uterine contraction. The fact that adrenergic nerve terminals decrease in number in late pregnancy (Klopper and Gardner 1973) could explain, at least in part, the decreased sensitivity of uterine muscle to ketamine in late pregnancy.
The contraction of the uterine muscle produced by ketamine in the first and probably second trimester (Galloon, 1973) is ideal from an operative point of view, as it enables safe curettage and decreases blood loss. The lack of response at term means that uterine blood flow and thus feto-placental exchange is not diminished.
EFFETS DE LA KETAMINE SUR L'UTERUS GRAVIDE

RESUME
La pression intra-uterine a ete enregistree en placant un catheter de Foley dans Pespace extra-amniotique, avant la fin de la grossesse de 25 personnes et avant de proceder a une operation cesarienne sur 12 autres. Les effets de Padministration par voie i.v. de ketamine a raison de 2 mg par kg du poids du corps, de thiopentone de sodium a raison de 4 mg kg" 1 et d'ergometrine sur la base de 0,5 mg, et de xylocaine 20 ml a 0,5% par voie intra-cervicale ont ete mesures au cours du premier trimestre de la grossesse. Les effets de la ketamine et du thiopentone de sodium administres par voie i.v. ont ete evalues vers la fin de la grossesse. On a trouve que la ketamine produisait des contractions marines au debut de la grossesse (augmentation moyenne de 16,1 mm Hg) egales a celles produites par I'ergometrine (augmentation moyenne 14,8 mm Hg), mais n'avait aucun effet vers la fin de la grossesse (diminution moyenne -1,33 mm Hg). La xylocaine administree comme blocage paracervical en debut de grossesse n'avait aucun effet significatif sur la pression intra-uterine (augmentation moyenne 0,33 mm Hg). Le thiopentone de sodium administr£ en fin de grossesse n'a eu aucun effet significatif sur la pression intra-uterine (diminution moyenne -4,28 mm Hg lors du premier trimestre de grossesse et -2,22 mm Hg a terme). 
SUMARIO
Se registro la presion intra-uterina en 25 pacientes antes del termino del embarazo y en 12 pacientes antes de la operation cesarea, al colocarles una sonda de Foley en el espacio extra-amniotico. Los efectos de la administration i.v. de 2 mg kg" 1 peso corporal de quetamina, de 4 mg kg" 1 peso corporal de tiopentona sodica y de 0,5 mg de ergometrina, asi como de xilocaina al 0,5% 20 ml intra-cervical fueron medidos en el primer trimestre del embarazo, y los de la quetamina y tiopentona sodica i.v. en la ultima parte del mismo. Se establecio que la quetamina ocasionaba contracciones uterinas (aumento medio 16,1 mm Hg) iguales a las de la ergometrina (aumento medio 14,8 mm Hg) en la primera parte del embarazo, pero no tenia ningun efecto (aumento medio -1,33 mm Hg) en la ultima parte del mismo. La xilocaina administrada como bloque paracervical en la primera parte del embarazo no tenia efectos significativos algunos en la presion intra-uterina (aumento medio 0,33 mm Hg). La tiopentona sodica (aumento medio -4,28 mm Hg en el primer trimestre y -2,22 mm Hg al termino) no tenia ningun efecto significativo en la presion intra-uterina en la ultima parte del embarazo.
